Longer Duration DAPT in Medically Treated MI: What is the Strength of the Evidence?

A few studies have demonstrated the benefit of dual antiplatelet therapy (DAPT) during the first 3-12 months after AMI in medically managed patients (1-3). However, the benefit of more prolonged DAPT is poorly defined. The guidelines from national societies on the use of antiplatelet therapy after acute coronary syndromes (ACS) with or without percutaneous coronary intervention (PCI)/stenting continue to evolve, with more recent guidelines recommending a reduced duration and intensity of therapy in certain situations (4, 5).
Source: The American Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research